Practice of medicine; creating the Supervised Physicians Act; limiting scope of supervised practice; directing specified Boards to promulgate certain rules; requiring collaborative practice arrangements; creating certain exemptions; effective date.
HB2051 creates the “Supervised Physicians Act,” a new framework for certain recent Oklahoma medical school graduates to practice medicine under a temporary, supervised license. To qualify, a graduate must be a U.S. citizen or resident, have passed USMLE Steps 1 and 2 (or equivalent) in the same calendar year as graduation, graduate from an Oklahoma medical or osteopathic school, and enter into a written supervised physician collaborative practice arrangement with an Oklahoma-licensed supervising physician. The bill requires the supervising physician to be board-certified in the same specialty, to directly supervise the supervised physician, and to accept full responsibility for the services provided.
The bill sets detailed rules for these arrangements, including required disclosures to patients, identification badges, reporting to the licensing boards, chart review of 100% of the supervised physician’s services, and limits on the number of supervised physicians a supervising physician may oversee at one time. It also authorizes the State Board of Medical Licensure and Supervision and the State Board of Osteopathic Examiners to adopt rules on temporary licensure, fees, treatment methods, and oversight. The temporary license is limited to two years from graduation, is not renewable, and the act expressly states it is not an alternative pathway to full licensure.
HB2051 also amends the allopathic and osteopathic licensing statutes to align them with the new supervised practice structure and to preserve existing exemptions and telemedicine-related provisions. The bill clarifies that supervised physicians may prescribe, administer, or dispense drugs within the arrangement, but may not prescribe controlled dangerous substances. It further provides that the supervised physician framework applies only in inpatient hospital settings in facilities accredited by the Accreditation Council for Graduate Medical Education, and that in certain hospital settings the collaborative arrangement can supersede hospital medication-order rules if approved by the hospital’s medical staff and pharmaceutical therapeutics committee.
The overall sentiment in the legislative history appears generally favorable, with the bill advancing through House committees, passing the House on third reading by a wide margin, and then receiving a favorable Senate committee vote. The votes suggest broad support for creating a structured supervised-practice pathway, likely viewed as a workforce or training measure for new graduates. At the same time, the narrow committee margins and the bill’s extensive supervision requirements indicate that lawmakers were attentive to patient-safety and oversight concerns.
The main points of contention appear to be the scope of authority given to supervised physicians and the degree of control retained by supervising physicians and licensing boards. The bill tightly limits practice to written arrangements, requires same-location practice, bars patient care during the supervising physician’s absence, and mandates full chart review, reflecting concern about ensuring adequate supervision. Another likely issue is that the bill is limited to Oklahoma medical school graduates and inpatient ACGME-accredited settings, which narrows eligibility and may have been intended to address concerns about quality control and the bill’s reach.
HB2051 would create new statutory sections in Title 59 establishing a temporary supervised-physician licensure category and a mandatory collaborative practice arrangement for eligible Oklahoma medical school graduates. It also amends the allopathic and osteopathic licensing acts to integrate this new category, authorize board rulemaking, and set enforcement, disclosure, reporting, and discipline provisions. The bill affects medical school graduates, supervising physicians, hospitals, and the two state licensing boards, while preserving existing licensure rules and exemptions for other practitioners and certain out-of-state sports-related practice.
The bill appears to have received generally positive treatment in committee and on the floor, with multiple “do pass” recommendations and strong House passage. The Senate committee vote was also favorable, though not unanimous, suggesting support tempered by caution. Overall, the discussion implied by the bill’s structure and voting pattern points to a consensus that supervised practice should be allowed, but only under strict oversight and limited circumstances.
The central contention is how much independence, if any, to give newly graduated physicians before full licensure. Supporters of the bill appear to favor a controlled pathway that helps recent graduates begin practice and address workforce needs, while opponents or skeptics likely focused on patient safety, supervision quality, and whether the arrangement could function as a de facto alternative licensure track. The bill responds to those concerns by imposing tight limits on eligibility, requiring board-certified supervision, patient disclosures, chart review, reporting, and board rulemaking, and by excluding controlled dangerous substance prescribing.